PL356990A1 - Pochodne izoksazolokarboksyamidu - Google Patents
Pochodne izoksazolokarboksyamiduInfo
- Publication number
- PL356990A1 PL356990A1 PL00356990A PL35699000A PL356990A1 PL 356990 A1 PL356990 A1 PL 356990A1 PL 00356990 A PL00356990 A PL 00356990A PL 35699000 A PL35699000 A PL 35699000A PL 356990 A1 PL356990 A1 PL 356990A1
- Authority
- PL
- Poland
- Prior art keywords
- alpha1
- receptor antagonists
- adrenergic receptor
- isoxazolecarboxamide
- derivatives
- Prior art date
Links
- LKYNGTHMKCTTQC-UHFFFAOYSA-N 1,2-oxazole-3-carboxamide Chemical class NC(=O)C=1C=CON=1 LKYNGTHMKCTTQC-UHFFFAOYSA-N 0.000 title 1
- 239000000674 adrenergic antagonist Substances 0.000 title 1
- 102000030619 alpha-1 Adrenergic Receptor Human genes 0.000 title 1
- 108020004102 alpha-1 Adrenergic Receptor Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999MI002173A IT1314191B1 (it) | 1999-10-18 | 1999-10-18 | Derivati isossazolcarbossamidici |
| PCT/EP2000/010144 WO2001029015A2 (en) | 1999-10-18 | 2000-10-16 | Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL356990A1 true PL356990A1 (pl) | 2004-07-12 |
Family
ID=11383797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL00356990A PL356990A1 (pl) | 1999-10-18 | 2000-10-16 | Pochodne izoksazolokarboksyamidu |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1226131B1 (pl) |
| JP (1) | JP2003512362A (pl) |
| KR (1) | KR20020038944A (pl) |
| CN (1) | CN1139579C (pl) |
| AR (1) | AR029400A1 (pl) |
| AT (1) | ATE256670T1 (pl) |
| AU (1) | AU757614B2 (pl) |
| BR (1) | BR0014851A (pl) |
| CA (1) | CA2385472A1 (pl) |
| DE (1) | DE60007347T2 (pl) |
| DK (1) | DK1226131T3 (pl) |
| ES (1) | ES2210033T3 (pl) |
| HK (1) | HK1044940A1 (pl) |
| HU (1) | HUP0203184A3 (pl) |
| IL (1) | IL148837A0 (pl) |
| IT (1) | IT1314191B1 (pl) |
| MX (1) | MXPA02003432A (pl) |
| MY (1) | MY120400A (pl) |
| NO (1) | NO20021803L (pl) |
| NZ (1) | NZ517884A (pl) |
| PL (1) | PL356990A1 (pl) |
| PT (1) | PT1226131E (pl) |
| RU (1) | RU2002113096A (pl) |
| WO (1) | WO2001029015A2 (pl) |
| ZA (1) | ZA200203942B (pl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007042420A1 (en) | 2005-10-11 | 2007-04-19 | F. Hoffmann-La Roche Ag | Isoxazole derivatives |
| KR101103129B1 (ko) | 2005-11-09 | 2012-01-04 | 에프. 호프만-라 로슈 아게 | 3-아릴-아이속사졸-4-카본일-벤조퓨란 유도체 |
| RU2426731C2 (ru) | 2005-12-23 | 2011-08-20 | Ф. Хоффманн-Ля Рош Аг | Производные арил-изоксазоло-4-ил-оксадиазола |
| BRPI0620773A2 (pt) | 2005-12-27 | 2011-11-22 | Hoffmann La Roche | derivados de aril-isoxazol-4-il-imidazol |
| JP4913157B2 (ja) | 2006-01-17 | 2012-04-11 | エフ．ホフマン−ラ ロシュ アーゲー | ＧＡＢＡレセプター経由でのアルツハイマー病の処置に有用なアリール−イソオキサゾール−４−イル−イミダゾ［１，２−ａ］ピリジン誘導体 |
| MX2008014796A (es) | 2006-05-31 | 2008-12-02 | Hoffmann La Roche | Derivados de aril-4-etinil-isoxazol. |
| JP5416103B2 (ja) | 2007-06-22 | 2014-02-12 | エフ．ホフマン−ラ ロシュ アーゲー | イソオキサゾール−イミダゾール誘導体 |
| WO2009071464A1 (en) | 2007-12-04 | 2009-06-11 | F. Hoffmann-La Roche Ag | Isoxazolo-pyrazine derivatives |
| US7902201B2 (en) | 2007-12-04 | 2011-03-08 | Hoffmann-La Roche Inc. | Isoxazolo-pyrazine derivatives |
| US7943619B2 (en) | 2007-12-04 | 2011-05-17 | Hoffmann-La Roche Inc. | Isoxazolo-pyridazine derivatives |
| WO2010081851A1 (en) | 2009-01-14 | 2010-07-22 | Genoscience Pharma | Piperidin-4-ylpiperazine compounds for the treatment of hcv infection |
| TW201033201A (en) | 2009-02-19 | 2010-09-16 | Hoffmann La Roche | Isoxazole-isoxazole and isoxazole-isothiazole derivatives |
| US8389550B2 (en) | 2009-02-25 | 2013-03-05 | Hoffmann-La Roche Inc. | Isoxazoles / O-pyridines with ethyl and ethenyl linker |
| US8222246B2 (en) | 2009-04-02 | 2012-07-17 | Hoffmann-La Roche Inc. | Substituted isoxazoles |
| US8227461B2 (en) | 2009-04-30 | 2012-07-24 | Hoffmann-La Roche Inc. | Isoxazoles |
| MX2011011490A (es) | 2009-05-05 | 2011-11-18 | Hoffmann La Roche | Derivados de isoxazol-tiazol como agonistas inversos del receptor de acido gamma-aminobutirico a (gaba a), para usarse en el tratamiento de trastornos cognitivos. |
| AU2010244552A1 (en) | 2009-05-05 | 2011-09-29 | F. Hoffmann-La Roche Ag | Isoxazole-pyrazole derivatives |
| EP2427458B1 (en) | 2009-05-05 | 2014-05-07 | F.Hoffmann-La Roche Ag | Isoxazole-pyridazine derivatives |
| WO2010127976A1 (en) | 2009-05-05 | 2010-11-11 | F. Hoffmann-La Roche Ag | Isoxazole-pyridine derivatives |
| MX2011011484A (es) | 2009-05-07 | 2011-11-18 | Hoffmann La Roche | Derivados de isoxazol-piridina como moduladores del acido gamma-aminobutirico. |
| US8785435B2 (en) | 2011-10-20 | 2014-07-22 | Hoffmann-La Roche Inc. | Solid forms |
| CN113121540B (zh) * | 2020-01-15 | 2024-01-26 | 鲁南制药集团股份有限公司 | 一种西格列汀游离碱的合成方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1254469B (it) * | 1992-02-25 | 1995-09-25 | Recordati Chem Pharm | Derivati benzopiranici e benzotiopiranici |
| IT1266582B1 (it) * | 1993-07-30 | 1997-01-09 | Recordati Chem Pharm | Derivati (di)azacicloesanici e diazacicloeptanici |
| DE4425146A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung heterocyclischer Verbindungen |
-
1999
- 1999-10-18 IT IT1999MI002173A patent/IT1314191B1/it active
-
2000
- 2000-10-10 MY MYPI20004718A patent/MY120400A/en unknown
- 2000-10-16 JP JP2001531815A patent/JP2003512362A/ja active Pending
- 2000-10-16 HK HK02105918.6A patent/HK1044940A1/zh unknown
- 2000-10-16 KR KR1020027004663A patent/KR20020038944A/ko not_active Withdrawn
- 2000-10-16 CN CNB008143226A patent/CN1139579C/zh not_active Expired - Fee Related
- 2000-10-16 EP EP00992436A patent/EP1226131B1/en not_active Expired - Lifetime
- 2000-10-16 ES ES00992436T patent/ES2210033T3/es not_active Expired - Lifetime
- 2000-10-16 MX MXPA02003432A patent/MXPA02003432A/es not_active Application Discontinuation
- 2000-10-16 NZ NZ517884A patent/NZ517884A/en unknown
- 2000-10-16 AT AT00992436T patent/ATE256670T1/de not_active IP Right Cessation
- 2000-10-16 CA CA002385472A patent/CA2385472A1/en not_active Abandoned
- 2000-10-16 RU RU2002113096/04A patent/RU2002113096A/ru not_active Application Discontinuation
- 2000-10-16 PT PT00992436T patent/PT1226131E/pt unknown
- 2000-10-16 DE DE60007347T patent/DE60007347T2/de not_active Expired - Fee Related
- 2000-10-16 BR BR0014851-2A patent/BR0014851A/pt not_active IP Right Cessation
- 2000-10-16 DK DK00992436T patent/DK1226131T3/da active
- 2000-10-16 IL IL14883700A patent/IL148837A0/xx unknown
- 2000-10-16 AU AU28347/01A patent/AU757614B2/en not_active Ceased
- 2000-10-16 WO PCT/EP2000/010144 patent/WO2001029015A2/en not_active Ceased
- 2000-10-16 PL PL00356990A patent/PL356990A1/pl not_active Application Discontinuation
- 2000-10-16 HU HU0203184A patent/HUP0203184A3/hu unknown
- 2000-10-18 AR ARP000105475A patent/AR029400A1/es not_active Application Discontinuation
-
2002
- 2002-04-17 NO NO20021803A patent/NO20021803L/no not_active Application Discontinuation
- 2002-05-17 ZA ZA200203942A patent/ZA200203942B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY120400A (en) | 2005-10-31 |
| WO2001029015A2 (en) | 2001-04-26 |
| CN1379767A (zh) | 2002-11-13 |
| NO20021803L (no) | 2002-06-17 |
| AU2834701A (en) | 2001-04-30 |
| BR0014851A (pt) | 2002-06-11 |
| DE60007347D1 (de) | 2004-01-29 |
| ITMI992173A1 (it) | 2001-04-18 |
| IL148837A0 (en) | 2002-09-12 |
| DK1226131T3 (da) | 2004-04-19 |
| RU2002113096A (ru) | 2003-11-10 |
| ES2210033T3 (es) | 2004-07-01 |
| NO20021803D0 (no) | 2002-04-17 |
| ITMI992173A0 (it) | 1999-10-18 |
| CN1139579C (zh) | 2004-02-25 |
| HUP0203184A3 (en) | 2004-12-28 |
| MXPA02003432A (es) | 2002-08-20 |
| NZ517884A (en) | 2003-08-29 |
| AU757614B2 (en) | 2003-02-27 |
| ATE256670T1 (de) | 2004-01-15 |
| JP2003512362A (ja) | 2003-04-02 |
| WO2001029015A3 (en) | 2001-11-01 |
| ZA200203942B (en) | 2003-01-02 |
| AR029400A1 (es) | 2003-06-25 |
| HK1044940A1 (zh) | 2002-11-08 |
| HUP0203184A2 (hu) | 2003-01-28 |
| EP1226131B1 (en) | 2003-12-17 |
| KR20020038944A (ko) | 2002-05-24 |
| CA2385472A1 (en) | 2001-04-26 |
| DE60007347T2 (de) | 2004-09-02 |
| IT1314191B1 (it) | 2002-12-06 |
| PT1226131E (pt) | 2004-05-31 |
| EP1226131A2 (en) | 2002-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1211802A (en) | 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists | |
| PL357433A1 (pl) | Pochodne benzodiazepiny | |
| SI1224174T1 (en) | Benzodiazepine derivatives as metabotropic glutamate receptor antagonists | |
| EP1206262A4 (en) | Y NEUROPEPTID ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES | |
| PL356990A1 (pl) | Pochodne izoksazolokarboksyamidu | |
| EP1224173A4 (en) | PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR ANTAGONISTS | |
| AU8200501A (en) | 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists | |
| IL148058A0 (en) | Substituted 2-dialkylaminoalkylbiphenyl derivatives | |
| IL146112A0 (en) | Bradykinin receptor antagonists | |
| IL148623A0 (en) | Thienoisoxazolyl-and thienylpyrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists | |
| EP1248607A4 (en) | UROTENSIN II RECEPTOR ANTAGONISTS | |
| IL146151A0 (en) | Human-g-protein receptor | |
| IL145166A0 (en) | Biphenyl derivatives as antagonists of the neurokinine-1 receptor | |
| IL144299A0 (en) | N-triazolymethyl-piperazine derivatives as neurokinin receptor antagonists | |
| IL148043A0 (en) | Novel integrin receptor antagonists | |
| AU1100300A (en) | Piperidyloxadiazoles as dopamine receptor antagonists | |
| IL146146A0 (en) | Integrin receptor antagonists | |
| IL150272A0 (en) | Indole derivatives as mcp-1 receptor antagonists | |
| EG24179A (en) | Vitronectin receptor antagonists | |
| AU2574801A (en) | Selective iGLUR5 receptor antagonists | |
| GB0026327D0 (en) | Thrombin receptor antagonists | |
| AU5572500A (en) | Vegf receptor antagonists | |
| AU5168900A (en) | Il-8 receptor antagonists | |
| AU2512800A (en) | Alpha1-adrenergic receptor antagonists | |
| GB9923910D0 (en) | Prolactin receptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |